Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Eur Rev Med Pharmacol Sci ; 27(9): 4309-4315, 2023 05.
Artículo en Inglés | MEDLINE | ID: mdl-37203857

RESUMEN

OBJECTIVE: Efficacy of the COVID-19 vaccines in cancer patients, especially during their active treatment, are lacking. Most of the studies in the literature compared the immunity in cancer patients with a cross-sectional cohort or retrospectively. Our study investigated Sinovac-CoronaVac COVID-19 vaccine immunogenicity and compared it with natural COVID-19 disease in cancer patients during their cancer therapy. PATIENTS AND METHODS: A total of 111 patients with cancer and who are on active treatment were included in the study. This is a single-center study and was designed prospectively. Two group of patients were included in the study, natural disease and vaccinated group. RESULTS: A total of 111 patients were included in the study, 34 of whom had natural COVID-19 disease. Antibody levels following the first dose vaccine were 0.4 (0-1.9) U/ml while after the second dose of vaccine were 2.6 (1.0-7.25) U/ml. Immunogenicity levels were 82.4% in the natural disease group and 75.8% in the vaccinated group after the second shot of the vaccine. Immunogenicity rate was significantly higher in non-chemotherapy (receiving immunotehrapy/targeted therapy or biologic agent) group compared to chemotherapy drug (92.9% vs. 63.3%, p=0.004). There was a difference between the antibody levels following the first and second vaccination [median (IQR): 0.3 (0-1.0) and 3.3 (2.0-6.7), p=0.001, respectively]. CONCLUSIONS: The present study revealed that the Sinovac-CoronaVac vaccine showed an acceptable immunogenicity following two shots in cancer patients who were receiving active systemic therapy. On the other hand, natural disease immunogenicity was higher than vaccinated group.


Asunto(s)
COVID-19 , Neoplasias , Vacunas , Humanos , Vacunas contra la COVID-19 , Estudios Transversales , Estudios Retrospectivos , COVID-19/prevención & control , Neoplasias/tratamiento farmacológico
2.
West Indian med. j ; 57(4): 398-402, Sept. 2008. tab
Artículo en Inglés | LILACS | ID: lil-672386

RESUMEN

BACKGROUND: The aim of this study was to determine the prevalence of selected sexually transmitted diseases (STDs) and the level of knowledge and attitudes regarding HIV/AIDS among Turkish brothel based sex-workers (SWs). SUBJECTS AND METHODS: A pre-designed questionnaire was administered to 199 SWs to obtain their sexual behaviours and their level of knowledge of HIV/AIDS. The specimens collected for C trachomatis/N gonorrhoeae and human papillomavirus (HPV) were tested using Gen-Probe PACE 2 and HPV-screening assays, respectively. RESULTS: Aproximatelly sixty-seven per cent of the SWs knew that condoms afforded protection against HIV/AIDS and 62% reported continued use of condoms. Although most of the SWs had heard about HIV/AIDS, thorough knowledge of transmission and prevention was lacking. The overall estimated rates for C trachomatis/N gonorrhoeae and HPV were 18.6% and 9.7%, respectively. CONCLUSION: There is a need for further studies to generate more data on the prevalence of STDs and the knowledge of STDs in this population.


ANTECEDENTES: El objetivo de este estudio es determinar la pevalencia de las enfermedades de trasmisión sexual (ETS) seleccionadas, y el nivel de conocimientos y actitudes en relación con el VIH/SIDA entre las trabajadoras sexuales (TS) en burdeles turcos. SUJETOS Y MÉTODOS: Se aplicó un cuestionario prediseñado a 199 trabajadoras sexuales a fin de revelar sus comportamientos sexuales y su nivel de conocimientos acerca del VIH/SIDA. Las muestras de C trachomatis/N gonorrhoeae y virus del papiloma humano (VPH) recogidas, fueron analizadas mediante la sonda genética conocida como Gen-Probe PACE 2 y ensayos de pesquisaje de VPH, respectivamente. RESULTADO: Aproximadamente sesenta y siete por ciento de las TS sabían que los condones daban protección contra el VIH/SIDA, y el 62% reportó uso continuado de condones. Aunque la mayor parte de las TS habían oído acerca del VIH/SIDA, les faltaban conocimientos cabales sobre la trasmisión y prevención de ETS. Las tasas generales estimadas de C trachomatis/N gonorrhoeae y VPH fueron 18.6% y 9.7%, respectivamente. CONCLUSIÓN: Es necesario realizar estudios ulteriores a fin de generar más datos acerca de la prevalencia de las ETS y los conocimientos acerca de ellas en esta población.


Asunto(s)
Adulto , Femenino , Humanos , Persona de Mediana Edad , Infecciones por Chlamydia/epidemiología , Chlamydia trachomatis , Gonorrea/epidemiología , Infecciones por VIH/psicología , Infecciones por Papillomavirus/epidemiología , Trabajo Sexual , Síndrome de Inmunodeficiencia Adquirida/epidemiología , Síndrome de Inmunodeficiencia Adquirida/psicología , Infecciones por Chlamydia/psicología , Gonorrea/psicología , Infecciones por VIH/epidemiología , Conductas Relacionadas con la Salud , Educación en Salud , Conocimientos, Actitudes y Práctica en Salud , Infecciones por Papillomavirus/psicología , Prevalencia , Encuestas y Cuestionarios , Medición de Riesgo , Factores de Riesgo , Asunción de Riesgos , Turquía/epidemiología
3.
West Indian Med J ; 57(4): 398-402, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19566023

RESUMEN

BACKGROUND: The aim of this study was to determine the prevalence of selected sexually transmitted diseases (STDs) and the level of knowledge and attitudes regarding HIV/AIDS among Turkish brothel based sex-workers (SWs). SUBJECTS AND METHODS: A pre-designed questionnaire was administered to 199 SWs to obtain their sexual behaviours and their level of knowledge of HIV/AIDS. The specimens collected for C trachomatis/N gonorrhoeae and human papillomavirus (HPV) were tested using Gen-Probe PACE 2 and HPV-screening assays, respectively. RESULT: Aproximately sixty-seven per cent of the SWs knew that condoms afforded protection against HIV/AIDS and 62% reported continued use of condoms. Although most of the SWs had heard about HIV/AIDS, thorough knowledge of transmission and prevention was lacking. The overall estimated rates for C trachomatis/N gonorrhoeae and HPV were 18.6% and 9.7%, respectively. CONCLUSION: There is a need for further studies to generate more data on the prevalence of STDs and the knowledge of STDs in this population.


Asunto(s)
Infecciones por Chlamydia/epidemiología , Chlamydia trachomatis , Gonorrea/epidemiología , Infecciones por VIH/psicología , Infecciones por Papillomavirus/epidemiología , Trabajo Sexual , Síndrome de Inmunodeficiencia Adquirida/epidemiología , Síndrome de Inmunodeficiencia Adquirida/psicología , Adulto , Infecciones por Chlamydia/psicología , Femenino , Gonorrea/psicología , Infecciones por VIH/epidemiología , Conductas Relacionadas con la Salud , Educación en Salud , Conocimientos, Actitudes y Práctica en Salud , Humanos , Persona de Mediana Edad , Infecciones por Papillomavirus/psicología , Prevalencia , Medición de Riesgo , Factores de Riesgo , Asunción de Riesgos , Encuestas y Cuestionarios , Turquía/epidemiología
4.
Ann Acad Med Singap ; 33(6): 758-62, 2004 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-15608834

RESUMEN

INTRODUCTION: To determine the oropharyngeal carriage rates and serogroups of Neisseria meningitidis in primary school children in Manisa, Turkey as well as the prevalence and penicillin resistance of N. meningitidis. MATERIALS AND METHODS: Throat swabs obtained from 1128 children were cultured and recovered organisms were tested by disk diffusion method and the E-test for antimicrobial susceptibilities. RESULTS: The carriage rate of N. meningitidis in our region was 6.2% (71 strains) and the serogroups identified were serogroups A (28.1%), B (22.5%), C (35.2%), D (2.8%) and W-135 (11.2%). Penicillin resistance was found in 16 strains (22.5%), while beta-lactamase activity was found in none. CONCLUSIONS: The carriage rate of N. meningitidis and serogroups are similar to the rates reported in other countries. Continued surveillance of meningococci for antimicrobial resistance will allow early detection of changes in susceptibility patterns that might affect recommendations for chemoprophylaxis as well as for treatment.


Asunto(s)
Neisseria meningitidis/efectos de los fármacos , Neisseria meningitidis/aislamiento & purificación , Orofaringe/microbiología , Resistencia a las Penicilinas , Adolescente , Niño , Femenino , Humanos , Masculino , Turquía
5.
Middle East J Anaesthesiol ; 17(3): 371-8, 2003 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-14740591

RESUMEN

Guidelines for controlling possible contamination of laryngoscopes should be formulated with the benefit of relevant experimental data. In this study, the effects of five different disinfectants commonly used for the disinfection of laryngoscopes are evaluated. We formed 14 groups, with 10 blades in each. The first 7 groups were contaminated with hospital related meticillin resistant Staphylococcus aureus (MRSA), and the remaining 7 groups with hospital related multiple resistant Pseudomonas aeruginosa (PA). For the first group of blades, no disinfection procedure was carried out and, were assumed as a control group. Blades in remaining groups were rested for 10 minutes in containers containing 70% alcohol (II), 1/100 dilution of cetrimide (III), 1/100 dilution of chlorhexidine (IV), 1/10 dilution of chlorhexidine (V), 1/10 dilution of povidone iodine (VI), and 1/100 dilution of ammonium chloride (VII). Disinfectant used in a group was considered effective when growth was seen in 5 or less than 5 plates representing that group. All disenfectants tested were found effective on decontamination of laryngoscopes. Five different moderate level disinfectants, which are commonly used for the disinfection of laryngoscopes, have been found effective even on resistant hospital microorganisms like MRSA and P. aeruginosa. They may be the choices of the disinfectants, especially 1/10 dilution of chlorhexidine gluconate and 1/100 dilution of ammonium chloride.


Asunto(s)
Descontaminación/métodos , Desinfectantes/farmacología , Laringoscopios , Pseudomonas aeruginosa/efectos de los fármacos , Staphylococcus aureus/efectos de los fármacos , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA